论文部分内容阅读
上海市卫生局、医疗保险局日前按规定程序组织相关医学、药学专家对制药企业申报要求进入公费、劳保药品报销范围的药品进行了严格的评审,同时对现有报销范围内的药品进行了甄别,经会同市财政局、市劳动局对专家评审结果进行认真研究后,公布了第四次修订后的药品报销范围。 新的药品报销范围增列药品75种,删除药品87种,使
The Shanghai Municipal Health Bureau and the Health Insurance Bureau organized related medical and pharmacy experts according to prescribed procedures to conduct a rigorous review of pharmaceuticals companies that applied for public and labor insurance reimbursement, and at the same time screened drugs within the current reimbursement range. After careful examination of the results of the expert review by the Municipal Bureau of Finance and the Municipal Labor Bureau, the fourth revised drug reimbursement scope was announced. The new drug reimbursement scope added 75 kinds of drugs and 87 kinds of drugs were deleted.